Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance.
Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance.
复制标题
DOI:
10.1158/0008-5472.can-13-0940
复制
发表时间:
2013-12-01
期刊:
影响因子:
11.2
通讯作者:
Kaufmann SH
中科院分区:
文献类型:
--
作者:
Dai H;Ding H;Meng XW;Lee SH;Schneider PA;Kaufmann SH
Bcl-2 is phosphorylated on Ser70 after treatment of cells with spindle poisons. Based on the cellular effects of overexpressing Bcl-2 S70E or S70A mutants, various studies have concluded that Ser70 phosphorylation either enhances or diminishes Bcl-2 function. In the present study, the ability of phosphorylated Bcl-2, as well as the S70E and S70A mutants, to bind and neutralize proapoptotic Bcl-2 family members under cell-free conditions and in intact cells was examined in an attempt to resolve this controversy. Surface plasmon resonance indicated that phosphorylated Bcl-2, Bcl-2 S70E and Bcl-2 S70A exhibit enhanced binding to Bim and Bak compared to unmodified Bcl-2. This enhanced binding reflected a readily detectable conformation change in the loop domain of Bcl-2. Further, Bcl-2 S70E and S70A bound more Bak and Bim than wildtype Bcl-2 in pulldowns and afforded greater protection against several chemotherapeutic agents. Importantly, binding of endogenous Bcl-2 to Bim also increased during mitosis, when Bcl-2 is endogenously phosphorylated; and disruption of this mitotic Bcl-2/ Bim binding with navitoclax or ABT-199, like Bcl-2 downregulation, enhanced the cytotoxicity of paclitaxel. Collectively these results provide not only a mechanistic basis for the enhanced anti-apoptotic activity of phosphorylated Bcl-2, but also an explanation for the ability of BH3 mimetics to enhance taxane sensitivity.